As pulmonary function decline has recently been proposed as a novel risk factor for glucose intolerance, insulin resistance and T2DM [10], there is a possible that decreasing serum SP-D protein in T2DM is connected with obesity, insulin resistance and inflammation [10]. The gene discussed is SFTPD; the disease is obesity due to melanocortin 4 receptor deficiency.